Krystal Biotech applies for biologics license for gene therapy


Krystal said its B-VEC is a noninvasive and topical therapy that treats a rare skin disorder.

Previous Truist unveils new Innovation and Technology Center at uptown HQ: 'It's a place people want to come and work'
Next AdventHealth names new chief people officer